4.7 Article

Developing Potent Human Uric Acid Transporter 1 (hURAT1) Inhibitors

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 54, 期 8, 页码 2701-2713

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jm1015022

关键词

-

资金

  1. J-Pharma Co., Ltd. (Tokyo, Japan)
  2. National Center for Research Resources at the National Institutes of Health (NCRR/NIH) [5UL1RR025780]
  3. Grants-in-Aid for Scientific Research [21390073] Funding Source: KAKEN

向作者/读者索取更多资源

The kidneys are a vital organ in the human body. They serve several purposes including homeostatic functions such as regulating extracellular fluid volume and maintaining acid-base and electrolyte balance and are essential regarding the excretion of metabolic waste. Furthermore, the kidneys play an important role in uric acid secretion/reabsorption. Abnormalities associated with kidney transporters have been associated with various diseases, such as gout. The current study utilized Xenopus oocytes expressing human uric acid transporter 1 (hURAT1; SLC22A12) as an in vitro method to investigate novel compounds and their ability to inhibit (14)C-uric acid uptake via hURAT1. We have prepared and tested a series of 2-ethyl-benzofuran compounds and probed the hURAT1 in vitro inhibitor structure activity relationship. As compared to dimethoxy analogues, monophenols formed on the C ring showed the best in vitro inhibitory potential. Compounds with submicromolar (i.e., IC(50) < 1000 nM) inhibitors were prepared by brominating the corresponding phenols to produce compounds with potent uricosuric activity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据